Heinz Burgmann

6.3k total citations
202 papers, 4.0k citations indexed

About

Heinz Burgmann is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Heinz Burgmann has authored 202 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Epidemiology, 55 papers in Infectious Diseases and 31 papers in Pharmacology. Recurrent topics in Heinz Burgmann's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Dialysis and Renal Disease Management (18 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Heinz Burgmann is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Dialysis and Renal Disease Management (18 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Heinz Burgmann collaborates with scholars based in Austria, Germany and United States. Heinz Burgmann's co-authors include Florian Thalhammer, Michael Frass, Wolfgang Poeppl, Selma Tobudic, Brigitte Stoiser, Thomas Staudinger, Sylvia Knapp, Heimo Lagler, Gottfried J. Locker and Ursula Hollenstein and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Heinz Burgmann

192 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heinz Burgmann Austria	34	1.5k	865	618	574	559	202	4.0k
Florian Thalhammer Austria	30	803 0.5×	713 0.8×	758 1.2×	342 0.6×	303 0.5×	132	2.7k
Martin Langer Italy	37	1.4k 0.9×	219 0.3×	293 0.5×	646 1.1×	1.1k 2.0×	170	4.9k
G. Potel France	30	1.1k 0.7×	1.0k 1.2×	719 1.2×	419 0.7×	615 1.1×	182	4.4k
Michael Cohen‐Wolkowiez United States	32	748 0.5×	795 0.9×	1.1k 1.7×	447 0.8×	512 0.9×	164	3.0k
Josep M. Gatell Spain	32	1.5k 1.0×	1.3k 1.5×	174 0.3×	163 0.3×	1.0k 1.8×	98	4.2k
C. Brun‐Buisson France	25	1.7k 1.2×	583 0.7×	162 0.3×	269 0.5×	1.0k 1.8×	61	3.7k
Shey‐Ying Chen Taiwan	34	1.1k 0.7×	1.2k 1.4×	110 0.2×	502 0.9×	336 0.6×	105	3.5k
Marc Lebel Canada	34	1.6k 1.1×	470 0.5×	886 1.4×	311 0.5×	504 0.9×	124	3.6k
B. Régnier France	42	2.9k 2.0×	1.7k 2.0×	423 0.7×	894 1.6×	673 1.2×	142	5.9k
Margaret M. Johnson United States	30	1.0k 0.7×	837 1.0×	158 0.3×	161 0.3×	1.4k 2.5×	113	4.1k

Countries citing papers authored by Heinz Burgmann

Since Specialization

Citations

This map shows the geographic impact of Heinz Burgmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Burgmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Burgmann more than expected).

Fields of papers citing papers by Heinz Burgmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinz Burgmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Burgmann. The network helps show where Heinz Burgmann may publish in the future.

Co-authorship network of co-authors of Heinz Burgmann

This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Burgmann. A scholar is included among the top collaborators of Heinz Burgmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Burgmann. Heinz Burgmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barousch, Wolfgang, et al.. (2024). 25 years of experience on the management of enterococcal infective endocarditis an observational study. Infection. 53(1). 467–474.

Selitsch, Brigitte, Barbara Steinlechner, Johannes Weber, et al.. (2024). Is the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice?. Clinical Microbiology and Infection. 30(6). 816–821. 5 indexed citations

Schmid, Katharina, Lisa Schneider, Norbert Cyran, et al.. (2024). Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy. BMC Infectious Diseases. 24(1). 899–899. 2 indexed citations

Tobudic, Selma, Elisabeth Simader, Felix Kartnig, et al.. (2023). The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination. Frontiers in Medicine. 10. 1049157–1049157. 5 indexed citations

Schneider, Lisa, et al.. (2023). Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model. Emerging Microbes & Infections. 13(1). 2292077–2292077. 3 indexed citations

Koblischke, Maximilian, Lisa Schneider, Edit Porpaczy, et al.. (2022). Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination. Cancers. 14(8). 1962–1962. 7 indexed citations

Tobudic, Selma, Christina Forstner, Heinz Burgmann, et al.. (2019). Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection. Infection. 47(6). 1013–1020. 50 indexed citations

Tobudic, Selma, Christina Forstner, Heinz Burgmann, et al.. (2018). Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna. Clinical Infectious Diseases. 67(5). 795–798. 134 indexed citations

Ratzinger, Franz, Helmuth Haslacher, Ralf Schmidt, et al.. (2017). 25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study. Scientific Reports. 7(1). 40646–40646. 18 indexed citations

10.

Schmidt, Ralf, Sabrina Jutz, Nadine Witzeneder, et al.. (2017). Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation. Scientific Reports. 7(1). 42191–42191. 37 indexed citations

11.

Ratzinger, Franz, Helmuth Haslacher, Wolfgang Poeppl, et al.. (2014). Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity. Scientific Reports. 4(1). 7438–7438. 87 indexed citations

12.

Lingscheid, Tilman, Selma Tobudic, Wolfgang Poeppl, Dieter Mitteregger, & Heinz Burgmann. (2013). In vitro Activity of Doripenem plus Fosfomycin against Drug-Resistant Clinical Blood Isolates. Pharmacology. 91(3-4). 214–218. 16 indexed citations

13.

Poeppl, Wolfgang, et al.. (2013). Exposure to Echinococcus multilocularis, Toxocara canis , and Toxocara cati in Austria: A Nationwide Cross-Sectional Seroprevalence Study. Vector-Borne and Zoonotic Diseases. 13(11). 798–803. 22 indexed citations

14.

Zedtwitz‐Liebenstein, Konstantin, Oliver Robak, Heinz Burgmann, & Michael Frass. (2013). Retrospective evaluation of antibody index of human parvovirus B19 as a prognostic factor in patients with dilated and ischemic cardiomyopathy. Journal of Medical Virology. 85(6). 1111–1114.

15.

Poeppl, Wolfgang, et al.. (2012). Cross-Sectional Survey of the Seroprevalence of Puumala Hantavirus in Austria. Vector-Borne and Zoonotic Diseases. 12(8). 709–711. 2 indexed citations

16.

Burgmann, Heinz, et al.. (2008). Hospital antibiotic management in Austria – results of the ABS maturity survey of the ABS International group. Wiener klinische Wochenschrift. 120(9-10). 280–283. 4 indexed citations

17.

Staudinger, Thomas, Brigitte Stoiser, Marcus Müllner, et al.. (2000). Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Critical Care Medicine. 28(5). 1322–1328. 251 indexed citations

18.

Staudinger, Thomas, Gottfried J. Locker, Klaus Laczika, et al.. (1998). Diagnostic Validity of Pulmonary Artery Catheterization for Residents at an Intensive Care Unit. 44(5). 902–906. 23 indexed citations

19.

Presterl, Elisabeth, Thomas Staudinger, Andrea Lassnigg, et al.. (1997). Cytokine Profile and Correlation to the APACHE III and MPM II Scores in Patients with Sepsis. American Journal of Respiratory and Critical Care Medicine. 156(3). 825–832. 91 indexed citations

20.

Burgmann, Heinz, et al.. (1992). Hepatic Energy Metabolism during Hypothermic Storage and Reperfusion Using Different Protecting Solutions. European Surgical Research. 24(6). 339–348. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact